Fny Investment Advisers, LLC Atea Pharmaceuticals, Inc. Transaction History
Fny Investment Advisers, LLC
- $164 Million
- Q1 2025
A detailed history of Fny Investment Advisers, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 5,000 shares of AVIR stock, worth $14,450. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,000Holding current value
$14,450% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding AVIR
# of Institutions
111Shares Held
50.6MCall Options Held
7.6KPut Options Held
38.7K-
Black Rock Inc. New York, NY9.12MShares$26.4 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$22 Million15.83% of portfolio
-
Tang Capital Management LLC San Diego, CA4.79MShares$13.8 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$13.5 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.34MShares$9.66 Million0.52% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $241M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...